- World Pharma News Home » User » worldpharmanews » Published
(a free service delivered by FeedBurner)
worldpharmanews / Published
Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donati
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Patients in Japan will benefit from the approval of three new Novartis medicines - Equa® (vildagliptin), marketed as Galvus® in the European Union, for the treatment of type 2 diabetes, Exforge® (val
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation
read more »
1 Comment Add this link to... Bury
1 Comment Add this link to... Bury
Posted by
worldpharmanews
59 days ago
(http://www.worldpharmanews.com)
Category: Conferences & Events |
Health 2.0 Europe, known for its live demos, will assemble speakers from 12 European countries and the U.S., in order to explain the world of Web 2.0 (both computer an read more »
Discuss Add this link to... Bury
Posted by
worldpharmanews
62 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
Genzyme Corp. (NASDAQ: GENZ) reported that preliminary fourth-quarter revenue was $1.08 billion, compared with $1.17 billion in the same period in 2008. For the year, revenue was $4.5 billion compare
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the United States (US) Food and Drug Administration (FDA) approved ACTEMRA (tocilizumab, RoACTEMRA in the European Union) for the treatment of adult
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk has initiated its first phase 1 clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a 2 million dollar payment to Emisphere Technologies, Inc., whose
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer (NYSE: PFE) and Strides Arcolab (BSE: 532531, NSE: STAR) announced a new collaboration, wherein Pfizer will commercialize off-patent sterile injectable and oral products in the United States t
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
